<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04217538</url>
  </required_header>
  <id_info>
    <org_study_id>19-ODONTO-01</org_study_id>
    <nct_id>NCT04217538</nct_id>
  </id_info>
  <brief_title>Observational Study of a Cohort of Patients With Hereditary Epidermolysis Bullosa</brief_title>
  <official_title>Observational Study of a Cohort of Patients With Hereditary Epidermolysis Bullosa That Come for Their Annual/Biannual Check up at This Medical Rare Disease Reference Centers (MRDRC) of This Disease in France and Belgium</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nice</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nice</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hereditary Epidermolysis Bullosa (EBH) are rare dermatologic diseases characterized by
      cutaneous and mucosa fragility. Oral manifestations of few small cohort have been published.
      The main objective of this multicentric cohort study first in Europe was to report the oral
      status of these patients that were consulted in the MRDRC of this disease in Nice (France),
      Toulouse (France) and Louvain (Belgium). Then a correlation between the oral characteristics
      and the EBH type will be made, in order to facilitate the management of patient care and the
      prevention program that can be established to improve their oral health.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 4, 2017</start_date>
  <completion_date type="Actual">December 11, 2019</completion_date>
  <primary_completion_date type="Actual">December 11, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Dental structural abnormalities and/or caries</measure>
    <time_frame>1 day</time_frame>
    <description>number of defect /dental caries dor each toth</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>gingival biotype</measure>
    <time_frame>1 day</time_frame>
    <description>clinical observation of gingiva (thin or thick)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>gingival status</measure>
    <time_frame>1 day</time_frame>
    <description>observation and classification of the gingiva (healthy, inflammed or hyperplastic)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>plaque and gingival index</measure>
    <time_frame>1 day</time_frame>
    <description>registration of plaque and gingival index according to the LoÃ« and Silness method</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>oral lesion</measure>
    <time_frame>1 day</time_frame>
    <description>number and localisation of the blister/scars/flanges scars on a sketch of a mouth</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">41</enrollment>
  <condition>Epidermolysis Bullosa</condition>
  <arm_group>
    <arm_group_label>EBH</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>clinical exam</intervention_name>
    <description>clinical oral examination</description>
    <arm_group_label>EBH</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients with EBH are recruted from the 2 MRDRC of the disease in France and the one of
        Belgium, the dental visit was/is organized for each visit/follow up of the patient in the
        center (annual or bianual visit)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patient with EBH

          -  patient consent for examination and use the clinical data for publication purpose

        Exclusion Criteria:

        -
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>7 Months</minimum_age>
    <maximum_age>78 Years</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Nice Hospital</name>
      <address>
        <city>Nice</city>
        <zip>06000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Toulouse University</name>
      <address>
        <city>Toucy</city>
        <zip>33000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>December 31, 2019</study_first_submitted>
  <study_first_submitted_qc>January 2, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 3, 2020</study_first_posted>
  <last_update_submitted>January 2, 2020</last_update_submitted>
  <last_update_submitted_qc>January 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 3, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epidermolysis Bullosa</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

